Stavropol sets the direction for a new GMP decade: 11th Russian GMP Conference kicks off

On September 15, 2026, the 11^th Russian GMP Conference with international engagement opened in Stavropol. The leading industry event of the year is held under the motto “New Decade of GMP: Innovation, Safety, Reliability” and will last until September 17. The event is organised by the Ministry of Industry and Trade of the Russian Federation in conjunction with the FSI “State Institute of Drugs and Good Practices” (FSI “SID & GP”).

Since 2016, the event has annually gathered leaders of the pharmaceutical industry, experts in Good Manufacturing Practices (GMP), government officials, regulators, and professional associations. This year’s event was no exception: those who set the rules of the game in the common EAEU market came to Stavropol.

The first day of the conference opened with a plenary session “Strategic priority: modern pharmaceuticals manufacturing.”

Anton Alikhanov, Minister of Industry and Trade of the Russian Federation, made a welcome speech to the conference participants.

“The pharmaceutical industry is a strategic priority of our country. The Russian pharmaceutical market is growing steadily. Hundreds of enterprises operate in the country, which also export products to more than 150 countries worldwide. Over the years, the Russian inspectorate has conducted more than 8,000 inspections both in Russia and abroad,” noted the Minister.

The industrial potential of the industry was highlighted by Dmitry Galkin, Director of the Department of Pharmaceutical and Medical Industry Development
of the Ministry of Industry and Trade of the Russian Federation. He emphasised that the tasks facing pharmaceutical manufacturers today should be viewed more broadly than merely as supplying the healthcare system with medicines — the long-term development of the pharmaceutical industry must be based on strengthening technological sovereignty, deepening local production, manufacturing innovative products, and exporting.

Vladislav Shestakov, Director of the FSI “SID & GP”, noted the role of the conference as a key platform for professional dialogue in the pharmaceutical industry. The speaker outlined the key lines of discussion: harmonisation of quality standards within the EAEU, strengthening interagency cooperation, development of contract manufacturing, production of high-tech medicines, and licensing issues. He emphasised that the Russian pharmaceutical industry continues to set global trends in certain categories — such as nuclear medicine, vaccine development, and biotechnological medicines.

The session was also attended by Chinara Mambetalieva, Deputy Director of the EEC Technical Regulation and Accreditation Department; Valentina Kosenko, Head of the Federal State Budgetary Institution “Scientific Centre for Expert Evaluation of Medicinal Products” (FSBI “SC EEMP”) of the Ministry of Health

of Russia; Dr. Solomon Onen, Technical Officer and GMP specialist at the African Medicines Agency; and representatives of the business community.

The dialogue of the event was focused on import substitution, local production, as well as the strategy for the common EAEU market and global regulatory trends. The event also  featured specialised discussion sessions where Russian and international experts thoroughly reviewed manufacturing authorization and inspection key topics, digitalisation of the pharmaceutical industry, and the practical implementation  of the requirements set out in EU GMP Annex 1.

The conference programme also included a wide range of topics facing the pharmaceutical industry: biopharmaceutical manufacturing, technological sovereignty, inspection and marketing authorization, technology transfer, and improvement of control and supervisory procedures. All this is not merely an exchange of views, but moving toward the concrete approaches that will shape the pharmaceutical industry for years to come.

The conference was held with the support of the key industry pharma companies:

General Partner – PETROVAX
Strategic Partner – NACIMBIO
Official Partner – PHARMASYNTEZ GROUP

Partners – R-Pharm, Geropharm, Gedeon Richter, AstraZeneca

Master Class Partner – Servier

Session Partners – PRO.MED.C S, Sotex, Rafarma, Pharmstandard, Promomed, Nanolek, Escom

Special Partners – Valenta Pharm, RHANA.

The conference programme and additional information are available on the official website: GOSGMP.RU.

What is GMP

 GMP (Good Manufacturing Practice) is an international standard regulating the conditions for t manufacturing of medicines to ensure their quality, safety, and efficacy. The rules provide for control at all stages: from the quality of raw materials and equipment to the qualification of personnel and documentation of every operation.

Common GMP rules have been in force within the EAEU since 2022. From March 1, 2026, inspections of Russian pharmaceutical manufacturers are carried out exclusively according to the Union standards. A GMP certificate is mandatory for marketing authorization of medicines to be placed in the markets of the EAEU member countries. The Russian GMP Conference is the main platform for developing common practical approaches in the conditions of the broad market.